期刊文献+

炎症反应及抗炎药物与阿尔茨海默病的研究进展 被引量:17

Recent advance in inflammatory reaction and anti-inflammatory drugs in Alzheimer's disease
原文传递
导出
摘要 阿尔茨海默病(Alzheimer's disease,AD)又称老年性痴呆,是一种常见的以认知功能进行性减退为特征的中枢神经系统(CNS)变性疾病,其病因和发病机制十分复杂.迄今仍未完全阐明。近年来越来越多的实验和临床证据表明.AD、帕金森病和多发性硬化等CNS疾病均与炎症反应有关.而对AD的研究表明:大量已知的炎症因子参与了AD的炎症损伤病理过程,在老年斑周围有大量活化的胶质细胞和炎症细胞,
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2012年第12期1282-1285,共4页 Chinese Journal of Neuromedicine
基金 国家自然科学基金(30873338) 国家科技重大专项课题(2009ZX09103-391)
关键词 阿尔茨海默病 炎症反应 抗炎药物 Alzheimer's disease Inflammation Anti-inflammatory agent
  • 相关文献

参考文献32

  • 1Heurtaux T, Michelucci A, Losciuto S, et al. Microglial activation depends on beta-amyloid conformation: role of the formylpeptide receptor 2[J]. J Neurochem, 2010, 114(2): 576-586.
  • 2Lee JW, Lee YK, Yuk DY, et al. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation [J]. J Neuroinflamm, 2008, 5(8): 37.
  • 3Farfara D, Lifshitz V, Frenkel D. Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease [J]. J Cell Mol Med, 2008, 12(3): 762-780.
  • 4杨小慧,姜招峰.小胶质细胞在阿尔茨海默病中的作用[J].生命的化学,2008,28f4):431-433.
  • 5Reed-Geaghan EG, Savage JC, Hise AG, et al. CD14 and Toll-like receptors 2 and 4 are required for fibrillar Aβ-stimulated microglial activation[J]. J Neurosci, 2009, 29(38): 11982-11992.
  • 6Walter S, Letiembre M, Liu Y, et al. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease [J]. Cell Physiol Biochem, 2007, 20(6): 947-956.
  • 7Jin J J, Kim HD, Maxwell JA, et al. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease[J]. J Neuroinflamm, 2008, 5(5): 23.
  • 8Granic I, Dolga AM, Nijholt IM, et al. Inflammation and NF-kappaB in Alzheimer's disease and diabetes[J]. J Alzheimers Dis, 2009, 16 (4): 809-821.
  • 9Blanco A, Alvarez S, Fresno M, et al. Arnyloid-β induces cyclooxygenase-2 and PGE2 release in human astrocytes in NF-KB dependent manner[J]. J Alzheimer's Dis, 2010, 22(2): 493-505.
  • 10Jiang QG, Heneka M, Landreth GE. The Role of Peroxisome Proliferator-Activated Receptor-3,(PPAR3,) in Alzheimer's Disease [J]. CNS Drugs, 2008, 22(1): 1-14.

二级参考文献27

  • 1Sastre M,Dewachter I,Rossner S,et al.Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma[J].Proc Natl Acad Sci USA,2006,103(2):443-448.
  • 2Risner ME,Saunders AM,Altman JFB,et al.Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease[J].Pharmacogenomics J,2006,6(4):246-254.
  • 3Bensinger SJ,Tontonoz P.Integration of metabolism and inflammation by lipid-activated nuclear receptors[J].Nature,2008,454(7203):470-477.
  • 4Luna-Medina R,Cortes-Canteli M,Alonso M,et al.,Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation[J].J Biol Chem,2005,280(22):21453-21462.
  • 5Loane DJ,Deighan BF,Clarke RM,et al.Interleukin-4 mediates the neuroprotective effects of rosiglitazone in the aged brain[J].Neurobiol Aging,2009,30(6):920-931.
  • 6Janabi N.Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-△12,14-prostaglandin J2 in activated human astrocytes,but not in human brain macrophages[J].Journal of Immunology,2002,168(9):4747-4755.
  • 7Lennon AM,Ramauge M,Dessouroux A,et al.MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-△12,14-prostaglandin J2 and the thiazolidinedione ciglitazone through peroxisome proliferators activator receptor γ-independent mechanisms involving reactive oxygenated species[J].J Biol Chem,2002,277(33):29681-29685.
  • 8Costello DA,O'Leary DM,Herron CE.Agonists of peroxisome proliferators-γ activated receptor-gamma attenuate the Abeta-mediated impairment of LTP in the hippocampus in vitro[J].Neuropharmacology,2005,49(3):359-366.
  • 9Du J,Sun B,Chen K,et al.Antagonist of peroxisome proliferator-activated receptor gamma induces cerebellar amyloid-beta levels and motor dysfunction in APP/PS1 transgenic mice[J].Biochem Biophys Res Commun,2009,384(3):357-361.
  • 10Tsukuda K,Mogi M,Iwanami J,et al.Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation[J].Hypertension,2009,54(4):782-787.

共引文献3

同被引文献143

引证文献17

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部